Filing Flows › Organon (OGN) › Recalls, complaints & regulation
Organon (OGN): recalls and Federal Register
Organon (OGN) beyond its filings: 0 recalls in the last 12 months (3 in five years, 0 Class I); 1 Federal Register document in a year.
Latest recalls
- 2024-06-19 · FDA drug · Asmanex Twisthaler, mometasone furoate inhalation powder, 220 mcg per actuation, 14 Metered Doses, Rx Only, Manuf. for: Organon LLC, a subsidiary of Organon & C
- 2024-06-19 · FDA drug · Asmanex Twisthaler, mometasone furoate inhalation powder, 220 mcg per actuation, 60 Metered Doses, Rx Only, Manuf. for: Organon LLC, a subsidiary of Organon & C
- 2024-06-19 · FDA drug · Asmanex Twisthaler, mometasone furoate inhalation powder, 220 mcg per actuation, 30 Metered Doses, Rx Only, Manuf. for: Organon LLC, a subsidiary of Organon & C
Organon's latest quarter
Organon, Q3 2026: revenue $1.6B (-2% year over year), operating margin 16.2%, net earnings $164M, operating cash flow $370M. The chart follows the revenue to costs, profit and cash.
Questions
Has Organon had any recalls?
3 recalls on file over five years from the FDA, CPSC and NHTSA; 0 in the last 12 months.
Updated Nov 8, 2026. Read automatically from SEC filings and public data; errors are possible. Not investment advice.